ING Groep NV reduced its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 64.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,064 shares of the company’s stock after selling 28,656 shares during the period. ING Groep NV’s holdings in Clorox were worth $2,609,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new stake in Clorox in the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its position in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc acquired a new position in Clorox during the 4th quarter valued at approximately $32,000. Finally, Catalyst Capital Advisors LLC purchased a new position in shares of Clorox in the third quarter worth $54,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CLX has been the topic of a number of research analyst reports. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Wells Fargo & Company boosted their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their price objective for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Finally, Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $158.21.
Clorox Stock Up 2.8 %
CLX opened at $157.41 on Friday. The company has a fifty day moving average of $157.72 and a two-hundred day moving average of $159.73. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 2.62 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm posted $2.16 earnings per share. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to Use the MarketBeat Excel Dividend Calculator
- DuPont’s Electronics Spinoff: The Start of Something Big
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.